SEC filing · 8-K

Vir Biotechnology, Inc.: Executive or director change

Vir Biotechnology appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026.

Filed October 1, 2026

Neutral news

What happened

Aziz Sawaf has been appointed Executive Vice President and Chief Financial Officer and principal financial officer, effective October 5, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov Press release (EX-99.1) All documents of this filing

Back to Vir Biotechnology, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.